移植物抗宿主病的临床试验
总计30440个结果
-
Columbia UniversityIncyte Corporation终止
-
Samsung Medical CenterMedipost Co Ltd.未知
-
Baylor Research InstituteMillennium Pharmaceuticals, Inc.未知
-
Affiliated Hospital to Academy of Military Medical...Beijing 302 Hospital未知
-
Massachusetts General HospitalAmerican Cancer Society, Inc.完全的
-
Assistance Publique - Hôpitaux de Paris主动,不招人干细胞移植并发症 | GVHD,急性 | GVH - 移植物抗宿主反应 | 同种异体疾病法国
-
National Heart, Lung, and Blood Institute (NHLBI)New York University and New York Genome Center招聘中
-
Grupo Espanol de trasplantes hematopoyeticos y...主动,不招人
-
Therakos, Inc., a Mallinckrodt Company终止
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Marrow... 和其他合作者完全的
-
Ohio State University Comprehensive Cancer Center撤销
-
China Medical University Hospital未知Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease
-
University Hospital, Basel, SwitzerlandGottfried und Julia Bangerter- Rhyner-Stiftung, Basel招聘中
-
University of LiegeKU Leuven; Maastricht University Medical Center; University Hospital, Ghent; Queen Fabiola Children... 和其他合作者招聘中
-
Dana-Farber Cancer Institute招聘中
-
Millennium Pharmaceuticals, Inc.完全的造血干细胞美国, 西班牙, 台湾, 澳大利亚, 加拿大, 新加坡, 大韩民国, 墨西哥, 瑞士, 日本, 德国, 挪威, 以色列, 俄罗斯联邦, 匈牙利, 英国, 意大利, 罗马尼亚, 巴西, 法国, 奥地利, 比利时, 葡萄牙, 希腊, 阿根廷, 波兰, 瑞典
-
Abramson Cancer Center of the University of Pennsylvania完全的造血干细胞移植 | 移植物抗宿主病
-
The Korean Society of Hematopoietic Stem Cell TransplantationHoffmann-La Roche未知
-
National Institute of Nursing Research (NINR)Fred Hutchinson Cancer Center终止
-
National Institute of Arthritis and Musculoskeletal...终止
-
Hospital Authority, Hong KongNovartis Pharmaceuticals; The Hong Kong Blood Cancer Foundation未知
-
Fred Hutchinson Cancer CenterFacet Biotech未知
-
Dana-Farber Cancer InstituteWyeth is now a wholly owned subsidiary of Pfizer; PDL BioPharma, Inc.终止